中国中免：8月26日召开董事会会议

Group 1 - The core point of the article is that China National Pharmaceutical Group (China National Immunization, SH 601888) held its 25th meeting of the fifth board of directors on August 26, 2025, to discuss external donation proposals and other documents [1] - For the fiscal year 2024, the revenue composition of China National Immunization is 98.74% from product sales and 1.26% from other businesses [1] - As of the report date, the market capitalization of China National Immunization is 147.7 billion yuan [1] Group 2 - The pet industry is experiencing significant growth, with a market size of 300 billion yuan, leading to a surge in stock prices for related companies [1]